Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 94-101 , 25 January 2010

The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART

  • Jinsong Peng

      Affiliations

    • TongJi Medical College, HuaZhong University of Science and Technology, Wuhan, People's Republic of China
    • Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
    • Wuhan Centers for Disease Control and Prevention, Wuhan, People's Republic of China
    • ,
  • Michael Vigorito

      Affiliations

    • Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
    • Department of Psychology, Seton Hall University, South Orange, New Jersey, USA
    • ,
  • Xiangqian Liu

      Affiliations

    • Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
    • ,
  • Dunjing Zhou

      Affiliations

    • Wuhan Centers for Disease Control and Prevention, Wuhan, People's Republic of China
    • ,
  • Xiongwen Wu

      Affiliations

    • TongJi Medical College, HuaZhong University of Science and Technology, Wuhan, People's Republic of China
    • ,
  • Sulie L. Chang

      Affiliations

    • Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
    • Department of Biological Sciences, Seton Hall University, South Orange, New Jersey, USA
    • Corresponding Author InformationCorresponding author. Institute of NeuroImmune Pharmacology, Seton Hall University, McNulty Hall, Room 309, South Orange, NJ 07079, USA. Tel.: +1 973 761 9456; fax: +1 973 275 2489.

Received 1 August 2009 ,Revised 24 September 2009 ,Accepted 24 September 2009.

References 

  1. Agbottah E, Zhang N, Dadgar S, Pumfery A, Wade JD, Zeng C, et al. Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virology. 2006;345:373–389
  2. Berger JR, Nath A. HIV dementia and the basal ganglia. Intervirology. 1997;40:122–131
  3. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch. Gen. Psychiatry. 2001;58:721–728
  4. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J. Clin. Invest. 1997;100:84–92
  5. Cedeno-Laurent F, Bryant J, Fishelevich R, Jones OD, Deng A, Eng ML, et al. Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1. J. Dermatol. Sci. 2009;53:112–119
  6. Chang SL, Beltran JA, Swarup S. Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J. Virol. 2007;81:8406–8411
  7. Cheynier R, Gratton S, Halloran M, Stahmer I, Letvin NL, Wain-Hobson S. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat. Med. 1998;4:421–427
  8. Dawood MR, Allan R, Fowke K, Embree J, Hammond GW. Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction. J. Clin. Microbiol. 1992;30:2279–2283
  9. De La Garza R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci. Biobehav. Rev. 2005;29:761–770
  10. Factor SA, Troche-Panetto M, Weaver SA. Dystonia in AIDS: report of four cases. Mov. Disord. 2003;18:1492–1498
  11. Grady C, Ropka M, Anderson R, Lane HC. Body composition in clinically stable men with HIV infection. J. Assoc. Nurses AIDS Care. 1996;7:29–38
  12. Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Moller A, et al. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. Aids. 2004;18:89–97
  13. Jones LE, Perelson AS. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull. Math. Biol. 2005;67:1227–1251
  14. Joshi PC, Raynor R, Fan X, Guidot DM. HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am. J. Respir. Cell Mol. Biol. 2008;39:218–226
  15. Klotman PE, Notkins AL. Transgenic models of human immunodeficiency virus type-1. Curr. Top. Microbiol. Immunol. 1996;206:197–222
  16. Lashomb AL, Vigorito M, Chang SL. Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J. Neurovirol. 2009;15:14–24
  17. Lassiter C, Fan X, Joshi PC, Jacob BA, Sutliff RL, Jones DP, et al. HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res. Ther. 2009;6:1
  18. Ostrowski MA, Krakauer DC, Li Y, Justement SJ, Learn G, Ehler LA, et al. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J. Virol. 1998;72:7772–7784
  19. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. U. S. A. 2001;98:9271–9276
  20. Royal W, Wang H, Jones O, Tran H, Bryant JL. A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat. J. Neuroimmunol. 2007;185:29–36
  21. Sclafani A. Carbohydrate taste, appetite, and obesity: an overview. Neurosci. Biobehav. Rev. 1987;11:131–153
  22. van Maanen M, Sutton RE. Rodent models for HIV-1 infection and disease. Curr. HIV Res. 2003;1:121–130
  23. Vigano A, Trabattoni D, Schneider L, Ottaviani F, Aliffi A, Longhi E, et al. Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J. Pediatr. 2006;148:389–391
  24. Vigorito M, LaShomb AL, Chang SL. Spatial learning and memory in HIV-1 transgenic rats. J. Neuroimmune Pharmacol. 2007;2:319–328
  25. Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, et al. Distribution of brain HIV load in AIDS. Brain Pathol. 1998;8:277–284
  26. Wiley CA, Achim CL, Christopherson C, Kidane Y, Kwok S, Masliah E, et al. HIV mediates a productive infection of the brain. AIDS. 1999;13:2055–2059

PII: S0165-5728(09)00382-8

doi: 10.1016/j.jneuroim.2009.09.014

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 94-101 , 25 January 2010

Article Tools

* Image Usage & Resolution